Fierce Pharma

MAY 31, 2023

government in a high-stakes HIV patent case, patient advocates are backing the U.S.’ government in a high-stakes HIV patent case, patient advocates are backing the U.S.’ Weeks after Gilead Sciences prevailed over the U.S. push to appeal. | Weeks after Gilead Sciences prevailed over the U.S. push to appeal.

Patients 184

Patients Government 184

World of DTC Marketing

AUGUST 16, 2020

I have been and continue to be critical of the pharma industry but it’s not out of spite or hate. It suddenly wasn’t about patients as much as it was about ROI and sales. Today, pharma CEOs make tens of millions of dollars because of one goal: sales. I am critical because I love this industry.

Pharma 196

Pharma Government Patients Leads 196

World of DTC Marketing

OCTOBER 20, 2020

There has to be a complete investigation as to why the patient suffered ill effects including the possibility that he/she had a known or unknown health condition. “It’s troubling, to say the least, and I can’t recommend any vaccine to a patient until I know a hell of a lot more,” said one physician I talked to.

Pharma 214

Pharma Government Physicians Safety 214

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 95

Government Recruitment Medicine Competition 95

Fierce Pharma

DECEMBER 12, 2023

Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages.

Medicine 359

Medicine Doctors Government Patients 359

World of DTC Marketing

JULY 2, 2021

Too many pharma CEOs are bad leaders because they fear failure, losing power, and focus too much on metrics not important to the rank and file. To date, I haven’t heard one pharma CEO speak up about the challenges the industry is facing (high drug prices, possible government negations with Medicare, lack of talent).

Pharma 181

Pharma Government Patients Manufacturing 181

Pharmaceutical Technology

MAY 17, 2023

At a lively panel at Financial Times US Pharma and Biotech Summit on May 16, panellists were at odds over whether the new legislation would improve treatment affordability or stifle pharma innovation. Meanwhile, the pharma industry is contending with a tough economic climate and a series of inflationary and supply chain pressures.

Food and Drug Administration 52

Food and Drug Administration Pharma Patients Pharmaceutical research 52

pharmaphorum

OCTOBER 26, 2022

When people think about pharma, they often think about “big” pharma: large, faceless corporations. And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. Caring for a global community.

Patients 82

Patients Pharma Consulting Transportation 82

European Pharmaceutical Review

MARCH 12, 2024

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. What is an effective solution?

Government 86

Government Pharma Ethics Training 86

European Pharmaceutical Review

JULY 12, 2022

According to a recent survey of patient groups, Roche, Pfizer, ViiV Healthcare and Gilead Sciences are among the top companies for implementing and reporting progress on environmental, social, governance (ESG) activities.

Patients 94

Patients Ethics Government Pharma 94

pharmaphorum

AUGUST 5, 2022

The largest pharma companies have all set themselves ambitious targets in recent years to improve representation for women and minority communities in their businesses, but are they meeting those diversity objectives? At the other end of the table, the worst performers were Astellas (+11), Eli Lilly (+21) and Teva Pharma (+28).

Pharma 98

Pharma Media Government Leads 98

Clarity Engagement Solutions

NOVEMBER 9, 2020

Let’s take the ecosystem definition as an example and extend it: ‘’A healthcare customer ecosystem is an interconnected set of entities and organizations each playing a role in providing healthcare to a geographic-specific patient population.’’. Providers, payers and suppliers, also a distribution supply chain and the patients themselves.

Pharma 91

Pharma Healthcare Healthcare Distribution 91

PM360

OCTOBER 28, 2022

With this in mind, in order to maximize the benefits of AI while mitigating its related risks, pharmaceutical incumbents and startups need to implement AI governance processes and tools. Promising AI Use Cases in Pharma. Current Guidelines Point the Way to Future Regulation on AI in Pharma.

Pharma 105

Pharma Food and Drug Administration Government Medicine 105

Impetus Digital

JANUARY 13, 2023

The growing role of artificial intelligence (AI) and the importance of the “human aspect” throughout Pharma operations. Environmental, Social & Governance (ESG) in the life sciences industry. Patient-centricity taking center stage. Out-of-the-box congress engagement & insight-gathering.

Pharma 94

Pharma Medical Patients Healthcare 94

PM360

JUNE 11, 2022

What is the value of a patient-centric approach if that approach doesn’t include the patients themselves? They want a patient inclusive approach. More specifically, what role is Medical Affairs playing in working with patients to create educational materials that would make sense to fellow patients?

Patients 98

Patients Medical Education Government 98

PM360

JUNE 26, 2023

Expanding Opportunities for Pharma Companies in Emerging Markets Despite these challenges, pharmaceutical companies have excellent reasons to launch their products in emerging markets. These partnerships can be with local governments, healthcare providers, local startups, and non-governmental organizations.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

Pharma Marketing Network

JANUARY 6, 2021

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. Trend #3: Relationships Despite Digital Congestion.

Marketing 98

Marketing Pharma Media Safety 98

pharmaphorum

NOVEMBER 1, 2022

a power Visa and ultimately the government could not deny. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. to make the patient experience as seamless as possible.

Patients 98

Patients Electronics Healthcare Healthcare 98

World of DTC Marketing

SEPTEMBER 7, 2021

Today’s pharma CEOs should prepare their organizations for the future, not wasting money with lobbying costs. Industry lobbyists claim that any government attempt to intervene in pharmaceutical companies’ price-setting would stifle innovation and prolong the fight against Covid-19. Bernie Sanders (I-Vt.),

Government 209

Government Prescription Healthcare Healthcare 209

pharmaphorum

JANUARY 27, 2023

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

Patients 100

Patients Pharmaceutical Medical Physicians 100

World of DTC Marketing

APRIL 7, 2021

QUICK READ: The compensation for pharma CEOs is starting to be reported and it’s off the charts. Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Government funding contributed to research associated with all 210 new drugs approved by the U.S.

Healthcare 162

Healthcare Healthcare Food and Drug Administration Pharma 162

European Pharmaceutical Review

MAY 1, 2024

By providing pharma companies with a real-life replicable model of a cloud-first manufacturing facility, we will drive forward the digital capability of pharma manufacturers” A new digital collaboration is set to take advantage of a manufacturing facility model featuring innovative technologies, accelerating how fast new medicines are made.

Medicine 88

Medicine Manufacturing Pharma Government 88

Eversana Intouch

OCTOBER 13, 2023

9 The government is playing an active role in creating SDOH initiatives Lately, there has been increased recognition that things need to change. Addressing SDOH is one way that a government program, Healthy People 2030, is trying “improve the health and well-being of all.”

Pharma 94

Pharma Education Government Pharmaceutical 94

PharmaKinnex

AUGUST 23, 2022

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! From new legislation to functional shifts in marketing and advertising, the pharma industry works hard every day to keep up with new regulatory requirements and the constantly evolving expectations of prescribers and patients. August 23, 2022.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

Clarivate

JUNE 29, 2023

We’re mindful of some challenges that life science and healthcare organizations must work through before this technology is mature enough for use in critical business decisions that may impact patient health. Our customers entrust our products and services to help them improve patient health, and we will not jeopardize that mission.

Patients 98

Patients Safety Healthcare Healthcare 98

European Pharmaceutical Review

MAY 2, 2024

Following publication of this white paper, the government requested that the MHRA outline the steps the agency is working on in relation to its expectations. According to the MHRA, artificial intelligence offers “improved efficiencies”, enabling patients in the UK to safely access medical products earlier.

Safety 95

Safety Medicine Government Medical 95

World of DTC Marketing

APRIL 19, 2021

A real conspiracy actually exists, and it is usually uncovered by journalists, whistleblowers, document dumps from a corporation or government, or it’s discovered by a government agency. . Rather, they often begin with niche groups mobilizing around their favored agendas like the distrust of pharma.

Government 190

Government Education Side effects Pharma 190

PM360

MAY 25, 2023

While conversations are ongoing about how payers can create impact in this space, it’s clear this is a new area of opportunity for pharma to help shift transactional relationships to collaborative ones, working together to help address this public health need. We get so little comparative effectiveness data from pharma.”

Pharma 92

Pharma Manufacturing Pharmaceutical manufacturing Management 92

World of DTC Marketing

NOVEMBER 24, 2020

And 68% said disinformation greatly impacts people’s confidence in government institutions. Pharma has two problems when it come to online health information: 1ne : The information is often too hard to understand for online health seekers. 2wo : Pharma websites are seen as a sales tool rather than a patient tool.

Media 277

Media Sales tools Pharma Government 277

Pharma Marketing Network

JULY 10, 2023

Pharmaceutical marketing is the process of communicating the benefits of a pharmaceutical product to potential patients and healthcare providers. Social media: Social media can be a powerful tool for pharmaceutical companies to connect with potential patients and healthcare providers.

Healthcare 40

Healthcare Healthcare Marketing Pharma 40

pharmaphorum

JANUARY 19, 2023

Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022. It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. he exclaimed.

Pharma 79

Pharma Competition Healthcare Healthcare 79

PharmExec

JANUARY 11, 2023

The parameters governing pharma promotional speech in digital and social media have struggled to keep pace with the rapidly evolving healthcare communications landscape. How can FDA play catch-up in advancing an agenda more reflective of industry and patient needs?

Media 72

Media Government FDA Pharma 72

World of DTC Marketing

OCTOBER 6, 2021

government $712 for the same amount of medicine or 40 times the price. Like the vast majority of medicines on the market, molnupiravir — which was originally investigated as a possible treatment for Venezuelan equine encephalitis — was developed using government funds. And while it costs $17.74 Merck charges the U.S.

Food and Drug Administration 198

Food and Drug Administration Government Medicine Food 198

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

PM360

SEPTEMBER 28, 2022

One fast-growing group in particular that requires a patient-centric and culturally relevant approach to marketing is the Hispanic audience, which is extremely diverse. The patient landscape continues to evolve. A study of Hispanic patients’ U.S. Evolving Demographics. Ethnic and/or racial groups comprise 100% of U.S.

Patients 98

Patients Marketing Doctors Healthcare 98

World of DTC Marketing

JANUARY 8, 2021

Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others. Wall Street has been speculating for a long time on which pharma company is going to make the most from the development of a Covid-19 vaccine.

Government 266

Government Safety FDA Pharma 266

Pharma Marketing Network

DECEMBER 17, 2021

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. HCP Engagement and Pharma Salesforces.

Pharma 105

Pharma Marketing Engineering Digital Media 105